Display options
Cite
Schooley AL, Kamudumuli PS, Vangala S, et al. CD4 Variability in Malawi: Implications for Use of a CD4 Threshold of 500 Cells/mm. Open Forum Infect Dis. 2016;3(3):ofw180doi: 10.1093/ofid/ofw180.
Schooley, A. L., Kamudumuli, P. S., Vangala, S., Tseng, C. H., Soko, C., Parent, J., Phiri, K., Jahn, A., Namarika, D., & Hoffman, R. M. (2016). CD4 Variability in Malawi: Implications for Use of a CD4 Threshold of 500 Cells/mm. Open forum infectious diseases, 3(3), ofw180. https://doi.org/10.1093/ofid/ofw180
Schooley, Alan L, et al. "CD4 Variability in Malawi: Implications for Use of a CD4 Threshold of 500 Cells/mm." Open forum infectious diseases vol. 3,3 (2016): ofw180. doi: https://doi.org/10.1093/ofid/ofw180
Schooley AL, Kamudumuli PS, Vangala S, Tseng CH, Soko C, Parent J, Phiri K, Jahn A, Namarika D, Hoffman RM. CD4 Variability in Malawi: Implications for Use of a CD4 Threshold of 500 Cells/mm. Open Forum Infect Dis. 2016 Aug 29;3(3):ofw180. doi: 10.1093/ofid/ofw180. eCollection 2016 Sep. PMID: 27704028; PMCID: PMC5047419.
Copy Download .nbib Format: NLM
Share it on

Open Forum Infect Dis. 2016 Aug 29;3(3):ofw180. doi: 10.1093/ofid/ofw180. eCollection 2016 Sep.

CD4 Variability in Malawi: Implications for Use of a CD4 Threshold of 500 Cells/mm.

Open forum infectious diseases

Alan L Schooley, Pocha Samuel Kamudumuli, Sitaram Vangala, Chi-Hong Tseng, Chifundo Soko, Julie Parent, Khumbo Phiri, Andreas Jahn, Dan Namarika, Risa M Hoffman

Affiliations

  1. Partners in Hope Medical Center, Lilongwe, Malawi; Division of Infectious Diseases.
  2. URC Malawi Lab Project , Lilongwe.
  3. Department of Medicine Statistics Core , University of California , Los Angeles.
  4. Partners in Hope Medical Center , Lilongwe , Malawi.
  5. University of Washington Department of Global Health , International Training and Education Center for Health and Ministry of Health , Lilongwe , Malawi.
  6. Division of Infectious Diseases.

PMID: 27704028 PMCID: PMC5047419 DOI: 10.1093/ofid/ofw180

[No abstract available.]

Keywords: CD4 cell count measurement; antiretroviral eligibility; antiretroviral therapy

References

  1. Clin Infect Dis. 2014 Feb;58(3):407-12 - PubMed
  2. N Engl J Med. 2015 Aug 27;373(9):795-807 - PubMed
  3. Clin Infect Dis. 1996 Jun;22(6):1096-8 - PubMed
  4. Am Rev Respir Dis. 1989 Jun;139(6):1446-51 - PubMed
  5. N Engl J Med. 2015 Aug 27;373(9):808-22 - PubMed
  6. Lung. 1997;175(6):387-94 - PubMed
  7. Afr J AIDS Res. 2008 Jul;7(2):237-42 - PubMed
  8. BMC Health Serv Res. 2015 Jun 25;15:247 - PubMed
  9. Ethiop Med J. 2011 Jul;49(3):187-97 - PubMed
  10. Lancet Infect Dis. 2014 Apr;14(4):281-90 - PubMed
  11. N Engl J Med. 2011 Aug 11;365(6):493-505 - PubMed
  12. Arch Intern Med. 2000 Mar 13;160(5):715-6 - PubMed
  13. N Engl J Med. 2010 Jul 15;363(3):257-65 - PubMed
  14. Trop Med Int Health. 2010 Jun;15 Suppl 1:43-7 - PubMed
  15. PLoS One. 2015 Mar 19;10(3):e0115019 - PubMed
  16. J Acquir Immune Defic Syndr. 1994 Nov;7(11):1122-33 - PubMed
  17. J Int AIDS Soc. 2012 Jan 30;15(1):3 - PubMed
  18. Genitourin Med. 1996 Feb;72(1):27-31 - PubMed
  19. N Engl J Med. 2009 Apr 30;360(18):1815-26 - PubMed
  20. J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):e98-107 - PubMed
  21. J Clin Immunol. 2005 Mar;25(2):127-33 - PubMed
  22. Niger J Clin Pract. 2014 Sep-Oct;17(5):543-8 - PubMed

Publication Types

Grant support